Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Index by author

October 01, 1999; Volume 27,Issue 10
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Abe, Tomio

    1. You have access
      Pharmacokinetic Interaction between Warfarin and a Uricosuric Agent, Bucolome: Application of In Vitro Approaches to Predicting In Vivo Reduction of (S)-Warfarin Clearance
      Harumi Takahashi, Toshitaka Kashima, Sosuke Kimura, Noboru Murata, Toshihiro Takaba, Kazunori Iwade, Tomio Abe, Hitoshi Tainaka, Toshio Yasumori and Hirotoshi Echizen
      Drug Metabolism and Disposition October 1999, 27 (10) 1179-1186;
  2. Aldridge, Susanna L. K.

    1. You have access
      Flavin-Containing Monooxygenase-MediatedN-Oxidation of the M1-Muscarinic Agonist Xanomeline
      Barbara J. Ring, Steven A. Wrighton, Susanna L. K. Aldridge, Kristian Hansen, Barbara Haehner and Lisa A. Shipley
      Drug Metabolism and Disposition October 1999, 27 (10) 1099-1103;
  3. Andersson, Tommy B.

    1. You have access
      Heterologous Expression and Kinetic Characterization of Human Cytochromes P-450: Validation of a Pharmaceutical Tool for Drug Metabolism Research
      Collen M. Masimirembwa, Charlotta Otter, Mikael Berg, Marie Jönsson, Brith Leidvik, Eva Jonsson, Thore Johansson, Assar Bäckman, Anders Edlund and Tommy B. Andersson
      Drug Metabolism and Disposition October 1999, 27 (10) 1117-1122;
  4. Appleton, Scott D.

    1. You have access
      Selective Inhibition of Heme Oxygenase, without Inhibition of Nitric Oxide Synthase or Soluble Guanylyl Cyclase, by Metalloporphyrins at Low Concentrations
      Scott D. Appleton, Marc L. Chretien, Brian E. McLaughlin, Hendrik J. Vreman, David K. Stevenson, James F. Brien, Kanji Nakatsu, Donald H. Maurice and Gerald S. Marks
      Drug Metabolism and Disposition October 1999, 27 (10) 1214-1219;

B

  1. Bäckman, Assar

    1. You have access
      Heterologous Expression and Kinetic Characterization of Human Cytochromes P-450: Validation of a Pharmaceutical Tool for Drug Metabolism Research
      Collen M. Masimirembwa, Charlotta Otter, Mikael Berg, Marie Jönsson, Brith Leidvik, Eva Jonsson, Thore Johansson, Assar Bäckman, Anders Edlund and Tommy B. Andersson
      Drug Metabolism and Disposition October 1999, 27 (10) 1117-1122;
  2. Balis, Frank M.

    1. You have access
      2′-β-Fluoro-2′,3′-dideoxyadenosine, Lodenosine, in Rhesus Monkeys: Plasma and Cerebrospinal Fluid Pharmacokinetics and Urinary Disposition
      Jeri S. Roth, Cynthia M. McCully, Frank M. Balis, David G. Poplack and James A. Kelley
      Drug Metabolism and Disposition October 1999, 27 (10) 1128-1132;
  3. Berg, Mikael

    1. You have access
      Heterologous Expression and Kinetic Characterization of Human Cytochromes P-450: Validation of a Pharmaceutical Tool for Drug Metabolism Research
      Collen M. Masimirembwa, Charlotta Otter, Mikael Berg, Marie Jönsson, Brith Leidvik, Eva Jonsson, Thore Johansson, Assar Bäckman, Anders Edlund and Tommy B. Andersson
      Drug Metabolism and Disposition October 1999, 27 (10) 1117-1122;
  4. Bergh, Jonas

    1. You have access
      Pharmacokinetic Models for the Saturable Distribution of Paclitaxel
      Mats O. Karlsson, Valeria Molnar, Agneta Freijs, Peter Nygren, Jonas Bergh and Rolf Larsson
      Drug Metabolism and Disposition October 1999, 27 (10) 1220-1223;
  5. Beschke, K.

    1. You have access
      Disposition and Chemical Stability of Telmisartan 1-O-Acylglucuronide
      T. Ebner, G. Heinzel, A. Prox, K. Beschke and H. Wachsmuth
      Drug Metabolism and Disposition October 1999, 27 (10) 1143-1149;
  6. Bolten, Suzanne

    1. You have access
      Evidence for Polymorphism in the Canine Metabolism of the Cyclooxygenase 2 Inhibitor, Celecoxib
      Susan K. Paulson, Leslie Engel, Beverly Reitz, Suzanne Bolten, Earl G. Burton, Timothy J. Maziasz, Bo Yan and Grant L. Schoenhard
      Drug Metabolism and Disposition October 1999, 27 (10) 1133-1142;
  7. Brien, James F.

    1. You have access
      Selective Inhibition of Heme Oxygenase, without Inhibition of Nitric Oxide Synthase or Soluble Guanylyl Cyclase, by Metalloporphyrins at Low Concentrations
      Scott D. Appleton, Marc L. Chretien, Brian E. McLaughlin, Hendrik J. Vreman, David K. Stevenson, James F. Brien, Kanji Nakatsu, Donald H. Maurice and Gerald S. Marks
      Drug Metabolism and Disposition October 1999, 27 (10) 1214-1219;
  8. Burton, Earl G.

    1. You have access
      Evidence for Polymorphism in the Canine Metabolism of the Cyclooxygenase 2 Inhibitor, Celecoxib
      Susan K. Paulson, Leslie Engel, Beverly Reitz, Suzanne Bolten, Earl G. Burton, Timothy J. Maziasz, Bo Yan and Grant L. Schoenhard
      Drug Metabolism and Disposition October 1999, 27 (10) 1133-1142;

C

  1. Cao, Ling

    1. You have access
      Induction of Rat Small Intestinal Cytochrome P-450 2J4
      Qing-Yu Zhang, Xinxin Ding, Deborah Dunbar, Ling Cao and Laurence S. Kaminsky
      Drug Metabolism and Disposition October 1999, 27 (10) 1123-1127;
  2. Cerniglia, Carl E.

    1. You have access
      Biotransformation of Doxepin by Cunninghamella elegans
      Joanna D. Moody, James P. Freeman and Carl E. Cerniglia
      Drug Metabolism and Disposition October 1999, 27 (10) 1157-1164;
  3. Chen, I-Wu

    1. You have access
      Effect of Dexamethasone on the Intestinal First-Pass Metabolism of Indinavir in Rats: Evidence of Cytochrome P-450 A and p-Glycoprotein Induction
      Jiunn H. Lin, Masato Chiba, I-Wu Chen, Joy A. Nishime, Florencia A. deLuna, Masayo Yamazaki and Yuh J. Lin
      Drug Metabolism and Disposition October 1999, 27 (10) 1187-1193;
  4. Cheng, Ziqiang

    1. You have access
      Studies on the Substrate Specificity of Human Intestinal UDP-Glucuronosyltransferases 1A8 and 1A10
      Ziqiang Cheng, Anna Radominska-Pandya and Thomas R. Tephly
      Drug Metabolism and Disposition October 1999, 27 (10) 1165-1170;
  5. Chiba, Kan

    1. You have access
      Isoform-Selective Metabolism of Mianserin by Cytochrome P-450 2D
      Toshio Chow, Toyoko Hiroi, Susumu Imaoka, Kan Chiba and Yoshihiko Funae
      Drug Metabolism and Disposition October 1999, 27 (10) 1200-1204;
  6. Chiba, Masato

    1. You have access
      Effect of Dexamethasone on the Intestinal First-Pass Metabolism of Indinavir in Rats: Evidence of Cytochrome P-450 A and p-Glycoprotein Induction
      Jiunn H. Lin, Masato Chiba, I-Wu Chen, Joy A. Nishime, Florencia A. deLuna, Masayo Yamazaki and Yuh J. Lin
      Drug Metabolism and Disposition October 1999, 27 (10) 1187-1193;
  7. Chow, Toshio

    1. You have access
      Isoform-Selective Metabolism of Mianserin by Cytochrome P-450 2D
      Toshio Chow, Toyoko Hiroi, Susumu Imaoka, Kan Chiba and Yoshihiko Funae
      Drug Metabolism and Disposition October 1999, 27 (10) 1200-1204;
  8. Chretien, Marc L.

    1. You have access
      Selective Inhibition of Heme Oxygenase, without Inhibition of Nitric Oxide Synthase or Soluble Guanylyl Cyclase, by Metalloporphyrins at Low Concentrations
      Scott D. Appleton, Marc L. Chretien, Brian E. McLaughlin, Hendrik J. Vreman, David K. Stevenson, James F. Brien, Kanji Nakatsu, Donald H. Maurice and Gerald S. Marks
      Drug Metabolism and Disposition October 1999, 27 (10) 1214-1219;
  9. Clayton, Eddie

    1. You have access
      Investigation of the Quantitative Metabolic Fate and Urinary Excretion of 3-Methyl-4-Trifluoromethylaniline and 3-Methyl-4-Trifluoromethylacetanilide in the Rat
      Graeme B. Scarfe, John C. Lindon, Jeremy K. Nicholson, Brian Wright, Eddie Clayton and Ian D. Wilson
      Drug Metabolism and Disposition October 1999, 27 (10) 1171-1178;

D

  1. deLuna, Florencia A.

    1. You have access
      Effect of Dexamethasone on the Intestinal First-Pass Metabolism of Indinavir in Rats: Evidence of Cytochrome P-450 A and p-Glycoprotein Induction
      Jiunn H. Lin, Masato Chiba, I-Wu Chen, Joy A. Nishime, Florencia A. deLuna, Masayo Yamazaki and Yuh J. Lin
      Drug Metabolism and Disposition October 1999, 27 (10) 1187-1193;
  2. Diaz, Gonzalo J.

    1. You have access
      Identification of Phase I Metabolites of 3-Methylindole Produced by Pig Liver Microsomes
      Gonzalo J. Diaz, Konstantine W. Skordos, Garold S. Yost and E. James Squires
      Drug Metabolism and Disposition October 1999, 27 (10) 1150-1156;
  3. Ding, Xinxin

    1. You have access
      Induction of Rat Small Intestinal Cytochrome P-450 2J4
      Qing-Yu Zhang, Xinxin Ding, Deborah Dunbar, Ling Cao and Laurence S. Kaminsky
      Drug Metabolism and Disposition October 1999, 27 (10) 1123-1127;
  4. Dorko, Kenneth

    1. You have access
      Troglitazone Increases Cytochrome P-450 3A Protein and Activity in Primary Cultures of Human Hepatocytes
      Vinod Ramachandran, Vsevolod E. Kostrubsky, Bernard J. Komoroski, Shimin Zhang, Kenneth Dorko, James E. Esplen, Stephen C. Strom and Raman Venkataramanan
      Drug Metabolism and Disposition October 1999, 27 (10) 1194-1199;
  5. Dunbar, Deborah

    1. You have access
      Induction of Rat Small Intestinal Cytochrome P-450 2J4
      Qing-Yu Zhang, Xinxin Ding, Deborah Dunbar, Ling Cao and Laurence S. Kaminsky
      Drug Metabolism and Disposition October 1999, 27 (10) 1123-1127;

E

  1. Ebner, T.

    1. You have access
      Disposition and Chemical Stability of Telmisartan 1-O-Acylglucuronide
      T. Ebner, G. Heinzel, A. Prox, K. Beschke and H. Wachsmuth
      Drug Metabolism and Disposition October 1999, 27 (10) 1143-1149;
  2. Echizen, Hirotoshi

    1. You have access
      Pharmacokinetic Interaction between Warfarin and a Uricosuric Agent, Bucolome: Application of In Vitro Approaches to Predicting In Vivo Reduction of (S)-Warfarin Clearance
      Harumi Takahashi, Toshitaka Kashima, Sosuke Kimura, Noboru Murata, Toshihiro Takaba, Kazunori Iwade, Tomio Abe, Hitoshi Tainaka, Toshio Yasumori and Hirotoshi Echizen
      Drug Metabolism and Disposition October 1999, 27 (10) 1179-1186;
  3. Edlund, Anders

    1. You have access
      Heterologous Expression and Kinetic Characterization of Human Cytochromes P-450: Validation of a Pharmaceutical Tool for Drug Metabolism Research
      Collen M. Masimirembwa, Charlotta Otter, Mikael Berg, Marie Jönsson, Brith Leidvik, Eva Jonsson, Thore Johansson, Assar Bäckman, Anders Edlund and Tommy B. Andersson
      Drug Metabolism and Disposition October 1999, 27 (10) 1117-1122;
  4. Engel, Leslie

    1. You have access
      Evidence for Polymorphism in the Canine Metabolism of the Cyclooxygenase 2 Inhibitor, Celecoxib
      Susan K. Paulson, Leslie Engel, Beverly Reitz, Suzanne Bolten, Earl G. Burton, Timothy J. Maziasz, Bo Yan and Grant L. Schoenhard
      Drug Metabolism and Disposition October 1999, 27 (10) 1133-1142;
  5. Esplen, James E.

    1. You have access
      Troglitazone Increases Cytochrome P-450 3A Protein and Activity in Primary Cultures of Human Hepatocytes
      Vinod Ramachandran, Vsevolod E. Kostrubsky, Bernard J. Komoroski, Shimin Zhang, Kenneth Dorko, James E. Esplen, Stephen C. Strom and Raman Venkataramanan
      Drug Metabolism and Disposition October 1999, 27 (10) 1194-1199;

F

  1. Freeman, James P.

    1. You have access
      Biotransformation of Doxepin by Cunninghamella elegans
      Joanna D. Moody, James P. Freeman and Carl E. Cerniglia
      Drug Metabolism and Disposition October 1999, 27 (10) 1157-1164;
  2. Freijs, Agneta

    1. You have access
      Pharmacokinetic Models for the Saturable Distribution of Paclitaxel
      Mats O. Karlsson, Valeria Molnar, Agneta Freijs, Peter Nygren, Jonas Bergh and Rolf Larsson
      Drug Metabolism and Disposition October 1999, 27 (10) 1220-1223;
  3. Funae, Yoshihiko

    1. You have access
      Isoform-Selective Metabolism of Mianserin by Cytochrome P-450 2D
      Toshio Chow, Toyoko Hiroi, Susumu Imaoka, Kan Chiba and Yoshihiko Funae
      Drug Metabolism and Disposition October 1999, 27 (10) 1200-1204;

H

  1. Haehner, Barbara

    1. You have access
      Flavin-Containing Monooxygenase-MediatedN-Oxidation of the M1-Muscarinic Agonist Xanomeline
      Barbara J. Ring, Steven A. Wrighton, Susanna L. K. Aldridge, Kristian Hansen, Barbara Haehner and Lisa A. Shipley
      Drug Metabolism and Disposition October 1999, 27 (10) 1099-1103;
  2. Hallström, Gösta

    1. You have access
      Mass Balance and Metabolism of [3H]Formoterol in Healthy Men after Combined i.v. and Oral Administration–Mimicking Inhalation
      Johan Rosenborg, Per Larsson, Kerstin Tegnér and Gösta Hallström
      Drug Metabolism and Disposition October 1999, 27 (10) 1104-1116;
  3. Hansen, Kristian

    1. You have access
      Flavin-Containing Monooxygenase-MediatedN-Oxidation of the M1-Muscarinic Agonist Xanomeline
      Barbara J. Ring, Steven A. Wrighton, Susanna L. K. Aldridge, Kristian Hansen, Barbara Haehner and Lisa A. Shipley
      Drug Metabolism and Disposition October 1999, 27 (10) 1099-1103;
  4. Heinzel, G.

    1. You have access
      Disposition and Chemical Stability of Telmisartan 1-O-Acylglucuronide
      T. Ebner, G. Heinzel, A. Prox, K. Beschke and H. Wachsmuth
      Drug Metabolism and Disposition October 1999, 27 (10) 1143-1149;
  5. Hiroi, Toyoko

    1. You have access
      Isoform-Selective Metabolism of Mianserin by Cytochrome P-450 2D
      Toshio Chow, Toyoko Hiroi, Susumu Imaoka, Kan Chiba and Yoshihiko Funae
      Drug Metabolism and Disposition October 1999, 27 (10) 1200-1204;

I

  1. Imaoka, Susumu

    1. You have access
      Isoform-Selective Metabolism of Mianserin by Cytochrome P-450 2D
      Toshio Chow, Toyoko Hiroi, Susumu Imaoka, Kan Chiba and Yoshihiko Funae
      Drug Metabolism and Disposition October 1999, 27 (10) 1200-1204;
  2. Iwade, Kazunori

    1. You have access
      Pharmacokinetic Interaction between Warfarin and a Uricosuric Agent, Bucolome: Application of In Vitro Approaches to Predicting In Vivo Reduction of (S)-Warfarin Clearance
      Harumi Takahashi, Toshitaka Kashima, Sosuke Kimura, Noboru Murata, Toshihiro Takaba, Kazunori Iwade, Tomio Abe, Hitoshi Tainaka, Toshio Yasumori and Hirotoshi Echizen
      Drug Metabolism and Disposition October 1999, 27 (10) 1179-1186;

J

  1. Jacobsen, Petter Balke

    1. You have access
      Biotransformation of Nonionic X-Ray Contrast Agents In Vivo and In Vitro
      Petter Balke Jacobsen, Åsmund Larsen, Roozbeh Konarboland and Tore Skotland
      Drug Metabolism and Disposition October 1999, 27 (10) 1205-1213;
  2. Johansson, Thore

    1. You have access
      Heterologous Expression and Kinetic Characterization of Human Cytochromes P-450: Validation of a Pharmaceutical Tool for Drug Metabolism Research
      Collen M. Masimirembwa, Charlotta Otter, Mikael Berg, Marie Jönsson, Brith Leidvik, Eva Jonsson, Thore Johansson, Assar Bäckman, Anders Edlund and Tommy B. Andersson
      Drug Metabolism and Disposition October 1999, 27 (10) 1117-1122;
  3. Jonsson, Eva

    1. You have access
      Heterologous Expression and Kinetic Characterization of Human Cytochromes P-450: Validation of a Pharmaceutical Tool for Drug Metabolism Research
      Collen M. Masimirembwa, Charlotta Otter, Mikael Berg, Marie Jönsson, Brith Leidvik, Eva Jonsson, Thore Johansson, Assar Bäckman, Anders Edlund and Tommy B. Andersson
      Drug Metabolism and Disposition October 1999, 27 (10) 1117-1122;
  4. Jönsson, Marie

    1. You have access
      Heterologous Expression and Kinetic Characterization of Human Cytochromes P-450: Validation of a Pharmaceutical Tool for Drug Metabolism Research
      Collen M. Masimirembwa, Charlotta Otter, Mikael Berg, Marie Jönsson, Brith Leidvik, Eva Jonsson, Thore Johansson, Assar Bäckman, Anders Edlund and Tommy B. Andersson
      Drug Metabolism and Disposition October 1999, 27 (10) 1117-1122;

K

  1. Kaminsky, Laurence S.

    1. You have access
      Induction of Rat Small Intestinal Cytochrome P-450 2J4
      Qing-Yu Zhang, Xinxin Ding, Deborah Dunbar, Ling Cao and Laurence S. Kaminsky
      Drug Metabolism and Disposition October 1999, 27 (10) 1123-1127;
  2. Karlsson, Mats O.

    1. You have access
      Pharmacokinetic Models for the Saturable Distribution of Paclitaxel
      Mats O. Karlsson, Valeria Molnar, Agneta Freijs, Peter Nygren, Jonas Bergh and Rolf Larsson
      Drug Metabolism and Disposition October 1999, 27 (10) 1220-1223;
  3. Kashima, Toshitaka

    1. You have access
      Pharmacokinetic Interaction between Warfarin and a Uricosuric Agent, Bucolome: Application of In Vitro Approaches to Predicting In Vivo Reduction of (S)-Warfarin Clearance
      Harumi Takahashi, Toshitaka Kashima, Sosuke Kimura, Noboru Murata, Toshihiro Takaba, Kazunori Iwade, Tomio Abe, Hitoshi Tainaka, Toshio Yasumori and Hirotoshi Echizen
      Drug Metabolism and Disposition October 1999, 27 (10) 1179-1186;
  4. Kelley, James A.

    1. You have access
      2′-β-Fluoro-2′,3′-dideoxyadenosine, Lodenosine, in Rhesus Monkeys: Plasma and Cerebrospinal Fluid Pharmacokinetics and Urinary Disposition
      Jeri S. Roth, Cynthia M. McCully, Frank M. Balis, David G. Poplack and James A. Kelley
      Drug Metabolism and Disposition October 1999, 27 (10) 1128-1132;
  5. Kimura, Sosuke

    1. You have access
      Pharmacokinetic Interaction between Warfarin and a Uricosuric Agent, Bucolome: Application of In Vitro Approaches to Predicting In Vivo Reduction of (S)-Warfarin Clearance
      Harumi Takahashi, Toshitaka Kashima, Sosuke Kimura, Noboru Murata, Toshihiro Takaba, Kazunori Iwade, Tomio Abe, Hitoshi Tainaka, Toshio Yasumori and Hirotoshi Echizen
      Drug Metabolism and Disposition October 1999, 27 (10) 1179-1186;
  6. Komoroski, Bernard J.

    1. You have access
      Troglitazone Increases Cytochrome P-450 3A Protein and Activity in Primary Cultures of Human Hepatocytes
      Vinod Ramachandran, Vsevolod E. Kostrubsky, Bernard J. Komoroski, Shimin Zhang, Kenneth Dorko, James E. Esplen, Stephen C. Strom and Raman Venkataramanan
      Drug Metabolism and Disposition October 1999, 27 (10) 1194-1199;
  7. Konarboland, Roozbeh

    1. You have access
      Biotransformation of Nonionic X-Ray Contrast Agents In Vivo and In Vitro
      Petter Balke Jacobsen, Åsmund Larsen, Roozbeh Konarboland and Tore Skotland
      Drug Metabolism and Disposition October 1999, 27 (10) 1205-1213;
  8. Kostrubsky, Vsevolod E.

    1. You have access
      Troglitazone Increases Cytochrome P-450 3A Protein and Activity in Primary Cultures of Human Hepatocytes
      Vinod Ramachandran, Vsevolod E. Kostrubsky, Bernard J. Komoroski, Shimin Zhang, Kenneth Dorko, James E. Esplen, Stephen C. Strom and Raman Venkataramanan
      Drug Metabolism and Disposition October 1999, 27 (10) 1194-1199;

L

  1. Larsen, Åsmund

    1. You have access
      Biotransformation of Nonionic X-Ray Contrast Agents In Vivo and In Vitro
      Petter Balke Jacobsen, Åsmund Larsen, Roozbeh Konarboland and Tore Skotland
      Drug Metabolism and Disposition October 1999, 27 (10) 1205-1213;
  2. Larsson, Per

    1. You have access
      Mass Balance and Metabolism of [3H]Formoterol in Healthy Men after Combined i.v. and Oral Administration–Mimicking Inhalation
      Johan Rosenborg, Per Larsson, Kerstin Tegnér and Gösta Hallström
      Drug Metabolism and Disposition October 1999, 27 (10) 1104-1116;
  3. Larsson, Rolf

    1. You have access
      Pharmacokinetic Models for the Saturable Distribution of Paclitaxel
      Mats O. Karlsson, Valeria Molnar, Agneta Freijs, Peter Nygren, Jonas Bergh and Rolf Larsson
      Drug Metabolism and Disposition October 1999, 27 (10) 1220-1223;
  4. Leidvik, Brith

    1. You have access
      Heterologous Expression and Kinetic Characterization of Human Cytochromes P-450: Validation of a Pharmaceutical Tool for Drug Metabolism Research
      Collen M. Masimirembwa, Charlotta Otter, Mikael Berg, Marie Jönsson, Brith Leidvik, Eva Jonsson, Thore Johansson, Assar Bäckman, Anders Edlund and Tommy B. Andersson
      Drug Metabolism and Disposition October 1999, 27 (10) 1117-1122;
  5. Lin, Jiunn H.

    1. You have access
      Effect of Dexamethasone on the Intestinal First-Pass Metabolism of Indinavir in Rats: Evidence of Cytochrome P-450 A and p-Glycoprotein Induction
      Jiunn H. Lin, Masato Chiba, I-Wu Chen, Joy A. Nishime, Florencia A. deLuna, Masayo Yamazaki and Yuh J. Lin
      Drug Metabolism and Disposition October 1999, 27 (10) 1187-1193;
  6. Lin, Yuh J.

    1. You have access
      Effect of Dexamethasone on the Intestinal First-Pass Metabolism of Indinavir in Rats: Evidence of Cytochrome P-450 A and p-Glycoprotein Induction
      Jiunn H. Lin, Masato Chiba, I-Wu Chen, Joy A. Nishime, Florencia A. deLuna, Masayo Yamazaki and Yuh J. Lin
      Drug Metabolism and Disposition October 1999, 27 (10) 1187-1193;
  7. Lindon, John C.

    1. You have access
      Investigation of the Quantitative Metabolic Fate and Urinary Excretion of 3-Methyl-4-Trifluoromethylaniline and 3-Methyl-4-Trifluoromethylacetanilide in the Rat
      Graeme B. Scarfe, John C. Lindon, Jeremy K. Nicholson, Brian Wright, Eddie Clayton and Ian D. Wilson
      Drug Metabolism and Disposition October 1999, 27 (10) 1171-1178;

M

  1. Marks, Gerald S.

    1. You have access
      Selective Inhibition of Heme Oxygenase, without Inhibition of Nitric Oxide Synthase or Soluble Guanylyl Cyclase, by Metalloporphyrins at Low Concentrations
      Scott D. Appleton, Marc L. Chretien, Brian E. McLaughlin, Hendrik J. Vreman, David K. Stevenson, James F. Brien, Kanji Nakatsu, Donald H. Maurice and Gerald S. Marks
      Drug Metabolism and Disposition October 1999, 27 (10) 1214-1219;
  2. Masimirembwa, Collen M.

    1. You have access
      Heterologous Expression and Kinetic Characterization of Human Cytochromes P-450: Validation of a Pharmaceutical Tool for Drug Metabolism Research
      Collen M. Masimirembwa, Charlotta Otter, Mikael Berg, Marie Jönsson, Brith Leidvik, Eva Jonsson, Thore Johansson, Assar Bäckman, Anders Edlund and Tommy B. Andersson
      Drug Metabolism and Disposition October 1999, 27 (10) 1117-1122;
  3. Maurice, Donald H.

    1. You have access
      Selective Inhibition of Heme Oxygenase, without Inhibition of Nitric Oxide Synthase or Soluble Guanylyl Cyclase, by Metalloporphyrins at Low Concentrations
      Scott D. Appleton, Marc L. Chretien, Brian E. McLaughlin, Hendrik J. Vreman, David K. Stevenson, James F. Brien, Kanji Nakatsu, Donald H. Maurice and Gerald S. Marks
      Drug Metabolism and Disposition October 1999, 27 (10) 1214-1219;
  4. Maziasz, Timothy J.

    1. You have access
      Evidence for Polymorphism in the Canine Metabolism of the Cyclooxygenase 2 Inhibitor, Celecoxib
      Susan K. Paulson, Leslie Engel, Beverly Reitz, Suzanne Bolten, Earl G. Burton, Timothy J. Maziasz, Bo Yan and Grant L. Schoenhard
      Drug Metabolism and Disposition October 1999, 27 (10) 1133-1142;
  5. McCully, Cynthia M.

    1. You have access
      2′-β-Fluoro-2′,3′-dideoxyadenosine, Lodenosine, in Rhesus Monkeys: Plasma and Cerebrospinal Fluid Pharmacokinetics and Urinary Disposition
      Jeri S. Roth, Cynthia M. McCully, Frank M. Balis, David G. Poplack and James A. Kelley
      Drug Metabolism and Disposition October 1999, 27 (10) 1128-1132;
  6. McLaughlin, Brian E.

    1. You have access
      Selective Inhibition of Heme Oxygenase, without Inhibition of Nitric Oxide Synthase or Soluble Guanylyl Cyclase, by Metalloporphyrins at Low Concentrations
      Scott D. Appleton, Marc L. Chretien, Brian E. McLaughlin, Hendrik J. Vreman, David K. Stevenson, James F. Brien, Kanji Nakatsu, Donald H. Maurice and Gerald S. Marks
      Drug Metabolism and Disposition October 1999, 27 (10) 1214-1219;
  7. Molnar, Valeria

    1. You have access
      Pharmacokinetic Models for the Saturable Distribution of Paclitaxel
      Mats O. Karlsson, Valeria Molnar, Agneta Freijs, Peter Nygren, Jonas Bergh and Rolf Larsson
      Drug Metabolism and Disposition October 1999, 27 (10) 1220-1223;
  8. Moody, Joanna D.

    1. You have access
      Biotransformation of Doxepin by Cunninghamella elegans
      Joanna D. Moody, James P. Freeman and Carl E. Cerniglia
      Drug Metabolism and Disposition October 1999, 27 (10) 1157-1164;
  9. Murata, Noboru

    1. You have access
      Pharmacokinetic Interaction between Warfarin and a Uricosuric Agent, Bucolome: Application of In Vitro Approaches to Predicting In Vivo Reduction of (S)-Warfarin Clearance
      Harumi Takahashi, Toshitaka Kashima, Sosuke Kimura, Noboru Murata, Toshihiro Takaba, Kazunori Iwade, Tomio Abe, Hitoshi Tainaka, Toshio Yasumori and Hirotoshi Echizen
      Drug Metabolism and Disposition October 1999, 27 (10) 1179-1186;

N

  1. Nakatsu, Kanji

    1. You have access
      Selective Inhibition of Heme Oxygenase, without Inhibition of Nitric Oxide Synthase or Soluble Guanylyl Cyclase, by Metalloporphyrins at Low Concentrations
      Scott D. Appleton, Marc L. Chretien, Brian E. McLaughlin, Hendrik J. Vreman, David K. Stevenson, James F. Brien, Kanji Nakatsu, Donald H. Maurice and Gerald S. Marks
      Drug Metabolism and Disposition October 1999, 27 (10) 1214-1219;
  2. Nicholson, Jeremy K.

    1. You have access
      Investigation of the Quantitative Metabolic Fate and Urinary Excretion of 3-Methyl-4-Trifluoromethylaniline and 3-Methyl-4-Trifluoromethylacetanilide in the Rat
      Graeme B. Scarfe, John C. Lindon, Jeremy K. Nicholson, Brian Wright, Eddie Clayton and Ian D. Wilson
      Drug Metabolism and Disposition October 1999, 27 (10) 1171-1178;
  3. Nishime, Joy A.

    1. You have access
      Effect of Dexamethasone on the Intestinal First-Pass Metabolism of Indinavir in Rats: Evidence of Cytochrome P-450 A and p-Glycoprotein Induction
      Jiunn H. Lin, Masato Chiba, I-Wu Chen, Joy A. Nishime, Florencia A. deLuna, Masayo Yamazaki and Yuh J. Lin
      Drug Metabolism and Disposition October 1999, 27 (10) 1187-1193;
  4. Nygren, Peter

    1. You have access
      Pharmacokinetic Models for the Saturable Distribution of Paclitaxel
      Mats O. Karlsson, Valeria Molnar, Agneta Freijs, Peter Nygren, Jonas Bergh and Rolf Larsson
      Drug Metabolism and Disposition October 1999, 27 (10) 1220-1223;

O

  1. Otter, Charlotta

    1. You have access
      Heterologous Expression and Kinetic Characterization of Human Cytochromes P-450: Validation of a Pharmaceutical Tool for Drug Metabolism Research
      Collen M. Masimirembwa, Charlotta Otter, Mikael Berg, Marie Jönsson, Brith Leidvik, Eva Jonsson, Thore Johansson, Assar Bäckman, Anders Edlund and Tommy B. Andersson
      Drug Metabolism and Disposition October 1999, 27 (10) 1117-1122;

P

  1. Paulson, Susan K.

    1. You have access
      Evidence for Polymorphism in the Canine Metabolism of the Cyclooxygenase 2 Inhibitor, Celecoxib
      Susan K. Paulson, Leslie Engel, Beverly Reitz, Suzanne Bolten, Earl G. Burton, Timothy J. Maziasz, Bo Yan and Grant L. Schoenhard
      Drug Metabolism and Disposition October 1999, 27 (10) 1133-1142;
  2. Poplack, David G.

    1. You have access
      2′-β-Fluoro-2′,3′-dideoxyadenosine, Lodenosine, in Rhesus Monkeys: Plasma and Cerebrospinal Fluid Pharmacokinetics and Urinary Disposition
      Jeri S. Roth, Cynthia M. McCully, Frank M. Balis, David G. Poplack and James A. Kelley
      Drug Metabolism and Disposition October 1999, 27 (10) 1128-1132;
  3. Prox, A.

    1. You have access
      Disposition and Chemical Stability of Telmisartan 1-O-Acylglucuronide
      T. Ebner, G. Heinzel, A. Prox, K. Beschke and H. Wachsmuth
      Drug Metabolism and Disposition October 1999, 27 (10) 1143-1149;

R

  1. Radominska-Pandya, Anna

    1. You have access
      Studies on the Substrate Specificity of Human Intestinal UDP-Glucuronosyltransferases 1A8 and 1A10
      Ziqiang Cheng, Anna Radominska-Pandya and Thomas R. Tephly
      Drug Metabolism and Disposition October 1999, 27 (10) 1165-1170;
  2. Ramachandran, Vinod

    1. You have access
      Troglitazone Increases Cytochrome P-450 3A Protein and Activity in Primary Cultures of Human Hepatocytes
      Vinod Ramachandran, Vsevolod E. Kostrubsky, Bernard J. Komoroski, Shimin Zhang, Kenneth Dorko, James E. Esplen, Stephen C. Strom and Raman Venkataramanan
      Drug Metabolism and Disposition October 1999, 27 (10) 1194-1199;
  3. Reitz, Beverly

    1. You have access
      Evidence for Polymorphism in the Canine Metabolism of the Cyclooxygenase 2 Inhibitor, Celecoxib
      Susan K. Paulson, Leslie Engel, Beverly Reitz, Suzanne Bolten, Earl G. Burton, Timothy J. Maziasz, Bo Yan and Grant L. Schoenhard
      Drug Metabolism and Disposition October 1999, 27 (10) 1133-1142;
  4. Ring, Barbara J.

    1. You have access
      Flavin-Containing Monooxygenase-MediatedN-Oxidation of the M1-Muscarinic Agonist Xanomeline
      Barbara J. Ring, Steven A. Wrighton, Susanna L. K. Aldridge, Kristian Hansen, Barbara Haehner and Lisa A. Shipley
      Drug Metabolism and Disposition October 1999, 27 (10) 1099-1103;
  5. Rosenborg, Johan

    1. You have access
      Mass Balance and Metabolism of [3H]Formoterol in Healthy Men after Combined i.v. and Oral Administration–Mimicking Inhalation
      Johan Rosenborg, Per Larsson, Kerstin Tegnér and Gösta Hallström
      Drug Metabolism and Disposition October 1999, 27 (10) 1104-1116;
  6. Roth, Jeri S.

    1. You have access
      2′-β-Fluoro-2′,3′-dideoxyadenosine, Lodenosine, in Rhesus Monkeys: Plasma and Cerebrospinal Fluid Pharmacokinetics and Urinary Disposition
      Jeri S. Roth, Cynthia M. McCully, Frank M. Balis, David G. Poplack and James A. Kelley
      Drug Metabolism and Disposition October 1999, 27 (10) 1128-1132;

S

  1. Scarfe, Graeme B.

    1. You have access
      Investigation of the Quantitative Metabolic Fate and Urinary Excretion of 3-Methyl-4-Trifluoromethylaniline and 3-Methyl-4-Trifluoromethylacetanilide in the Rat
      Graeme B. Scarfe, John C. Lindon, Jeremy K. Nicholson, Brian Wright, Eddie Clayton and Ian D. Wilson
      Drug Metabolism and Disposition October 1999, 27 (10) 1171-1178;
  2. Schoenhard, Grant L.

    1. You have access
      Evidence for Polymorphism in the Canine Metabolism of the Cyclooxygenase 2 Inhibitor, Celecoxib
      Susan K. Paulson, Leslie Engel, Beverly Reitz, Suzanne Bolten, Earl G. Burton, Timothy J. Maziasz, Bo Yan and Grant L. Schoenhard
      Drug Metabolism and Disposition October 1999, 27 (10) 1133-1142;
  3. Shipley, Lisa A.

    1. You have access
      Flavin-Containing Monooxygenase-MediatedN-Oxidation of the M1-Muscarinic Agonist Xanomeline
      Barbara J. Ring, Steven A. Wrighton, Susanna L. K. Aldridge, Kristian Hansen, Barbara Haehner and Lisa A. Shipley
      Drug Metabolism and Disposition October 1999, 27 (10) 1099-1103;
  4. Skordos, Konstantine W.

    1. You have access
      Identification of Phase I Metabolites of 3-Methylindole Produced by Pig Liver Microsomes
      Gonzalo J. Diaz, Konstantine W. Skordos, Garold S. Yost and E. James Squires
      Drug Metabolism and Disposition October 1999, 27 (10) 1150-1156;
  5. Skotland, Tore

    1. You have access
      Biotransformation of Nonionic X-Ray Contrast Agents In Vivo and In Vitro
      Petter Balke Jacobsen, Åsmund Larsen, Roozbeh Konarboland and Tore Skotland
      Drug Metabolism and Disposition October 1999, 27 (10) 1205-1213;
  6. Squires, E. James

    1. You have access
      Identification of Phase I Metabolites of 3-Methylindole Produced by Pig Liver Microsomes
      Gonzalo J. Diaz, Konstantine W. Skordos, Garold S. Yost and E. James Squires
      Drug Metabolism and Disposition October 1999, 27 (10) 1150-1156;
  7. Stevenson, David K.

    1. You have access
      Selective Inhibition of Heme Oxygenase, without Inhibition of Nitric Oxide Synthase or Soluble Guanylyl Cyclase, by Metalloporphyrins at Low Concentrations
      Scott D. Appleton, Marc L. Chretien, Brian E. McLaughlin, Hendrik J. Vreman, David K. Stevenson, James F. Brien, Kanji Nakatsu, Donald H. Maurice and Gerald S. Marks
      Drug Metabolism and Disposition October 1999, 27 (10) 1214-1219;
  8. Strom, Stephen C.

    1. You have access
      Troglitazone Increases Cytochrome P-450 3A Protein and Activity in Primary Cultures of Human Hepatocytes
      Vinod Ramachandran, Vsevolod E. Kostrubsky, Bernard J. Komoroski, Shimin Zhang, Kenneth Dorko, James E. Esplen, Stephen C. Strom and Raman Venkataramanan
      Drug Metabolism and Disposition October 1999, 27 (10) 1194-1199;

T

  1. Tainaka, Hitoshi

    1. You have access
      Pharmacokinetic Interaction between Warfarin and a Uricosuric Agent, Bucolome: Application of In Vitro Approaches to Predicting In Vivo Reduction of (S)-Warfarin Clearance
      Harumi Takahashi, Toshitaka Kashima, Sosuke Kimura, Noboru Murata, Toshihiro Takaba, Kazunori Iwade, Tomio Abe, Hitoshi Tainaka, Toshio Yasumori and Hirotoshi Echizen
      Drug Metabolism and Disposition October 1999, 27 (10) 1179-1186;
  2. Takaba, Toshihiro

    1. You have access
      Pharmacokinetic Interaction between Warfarin and a Uricosuric Agent, Bucolome: Application of In Vitro Approaches to Predicting In Vivo Reduction of (S)-Warfarin Clearance
      Harumi Takahashi, Toshitaka Kashima, Sosuke Kimura, Noboru Murata, Toshihiro Takaba, Kazunori Iwade, Tomio Abe, Hitoshi Tainaka, Toshio Yasumori and Hirotoshi Echizen
      Drug Metabolism and Disposition October 1999, 27 (10) 1179-1186;
  3. Takahashi, Harumi

    1. You have access
      Pharmacokinetic Interaction between Warfarin and a Uricosuric Agent, Bucolome: Application of In Vitro Approaches to Predicting In Vivo Reduction of (S)-Warfarin Clearance
      Harumi Takahashi, Toshitaka Kashima, Sosuke Kimura, Noboru Murata, Toshihiro Takaba, Kazunori Iwade, Tomio Abe, Hitoshi Tainaka, Toshio Yasumori and Hirotoshi Echizen
      Drug Metabolism and Disposition October 1999, 27 (10) 1179-1186;
  4. Tegnér, Kerstin

    1. You have access
      Mass Balance and Metabolism of [3H]Formoterol in Healthy Men after Combined i.v. and Oral Administration–Mimicking Inhalation
      Johan Rosenborg, Per Larsson, Kerstin Tegnér and Gösta Hallström
      Drug Metabolism and Disposition October 1999, 27 (10) 1104-1116;
  5. Tephly, Thomas R.

    1. You have access
      Studies on the Substrate Specificity of Human Intestinal UDP-Glucuronosyltransferases 1A8 and 1A10
      Ziqiang Cheng, Anna Radominska-Pandya and Thomas R. Tephly
      Drug Metabolism and Disposition October 1999, 27 (10) 1165-1170;

V

  1. Venkataramanan, Raman

    1. You have access
      Troglitazone Increases Cytochrome P-450 3A Protein and Activity in Primary Cultures of Human Hepatocytes
      Vinod Ramachandran, Vsevolod E. Kostrubsky, Bernard J. Komoroski, Shimin Zhang, Kenneth Dorko, James E. Esplen, Stephen C. Strom and Raman Venkataramanan
      Drug Metabolism and Disposition October 1999, 27 (10) 1194-1199;
  2. Vreman, Hendrik J.

    1. You have access
      Selective Inhibition of Heme Oxygenase, without Inhibition of Nitric Oxide Synthase or Soluble Guanylyl Cyclase, by Metalloporphyrins at Low Concentrations
      Scott D. Appleton, Marc L. Chretien, Brian E. McLaughlin, Hendrik J. Vreman, David K. Stevenson, James F. Brien, Kanji Nakatsu, Donald H. Maurice and Gerald S. Marks
      Drug Metabolism and Disposition October 1999, 27 (10) 1214-1219;

W

  1. Wachsmuth, H.

    1. You have access
      Disposition and Chemical Stability of Telmisartan 1-O-Acylglucuronide
      T. Ebner, G. Heinzel, A. Prox, K. Beschke and H. Wachsmuth
      Drug Metabolism and Disposition October 1999, 27 (10) 1143-1149;
  2. Wilson, Ian D.

    1. You have access
      Investigation of the Quantitative Metabolic Fate and Urinary Excretion of 3-Methyl-4-Trifluoromethylaniline and 3-Methyl-4-Trifluoromethylacetanilide in the Rat
      Graeme B. Scarfe, John C. Lindon, Jeremy K. Nicholson, Brian Wright, Eddie Clayton and Ian D. Wilson
      Drug Metabolism and Disposition October 1999, 27 (10) 1171-1178;
  3. Wright, Brian

    1. You have access
      Investigation of the Quantitative Metabolic Fate and Urinary Excretion of 3-Methyl-4-Trifluoromethylaniline and 3-Methyl-4-Trifluoromethylacetanilide in the Rat
      Graeme B. Scarfe, John C. Lindon, Jeremy K. Nicholson, Brian Wright, Eddie Clayton and Ian D. Wilson
      Drug Metabolism and Disposition October 1999, 27 (10) 1171-1178;
  4. Wrighton, Steven A.

    1. You have access
      Flavin-Containing Monooxygenase-MediatedN-Oxidation of the M1-Muscarinic Agonist Xanomeline
      Barbara J. Ring, Steven A. Wrighton, Susanna L. K. Aldridge, Kristian Hansen, Barbara Haehner and Lisa A. Shipley
      Drug Metabolism and Disposition October 1999, 27 (10) 1099-1103;

Y

  1. Yamazaki, Masayo

    1. You have access
      Effect of Dexamethasone on the Intestinal First-Pass Metabolism of Indinavir in Rats: Evidence of Cytochrome P-450 A and p-Glycoprotein Induction
      Jiunn H. Lin, Masato Chiba, I-Wu Chen, Joy A. Nishime, Florencia A. deLuna, Masayo Yamazaki and Yuh J. Lin
      Drug Metabolism and Disposition October 1999, 27 (10) 1187-1193;
  2. Yan, Bo

    1. You have access
      Evidence for Polymorphism in the Canine Metabolism of the Cyclooxygenase 2 Inhibitor, Celecoxib
      Susan K. Paulson, Leslie Engel, Beverly Reitz, Suzanne Bolten, Earl G. Burton, Timothy J. Maziasz, Bo Yan and Grant L. Schoenhard
      Drug Metabolism and Disposition October 1999, 27 (10) 1133-1142;
  3. Yasumori, Toshio

    1. You have access
      Pharmacokinetic Interaction between Warfarin and a Uricosuric Agent, Bucolome: Application of In Vitro Approaches to Predicting In Vivo Reduction of (S)-Warfarin Clearance
      Harumi Takahashi, Toshitaka Kashima, Sosuke Kimura, Noboru Murata, Toshihiro Takaba, Kazunori Iwade, Tomio Abe, Hitoshi Tainaka, Toshio Yasumori and Hirotoshi Echizen
      Drug Metabolism and Disposition October 1999, 27 (10) 1179-1186;
  4. Yost, Garold S.

    1. You have access
      Identification of Phase I Metabolites of 3-Methylindole Produced by Pig Liver Microsomes
      Gonzalo J. Diaz, Konstantine W. Skordos, Garold S. Yost and E. James Squires
      Drug Metabolism and Disposition October 1999, 27 (10) 1150-1156;

Z

  1. Zhang, Qing-Yu

    1. You have access
      Induction of Rat Small Intestinal Cytochrome P-450 2J4
      Qing-Yu Zhang, Xinxin Ding, Deborah Dunbar, Ling Cao and Laurence S. Kaminsky
      Drug Metabolism and Disposition October 1999, 27 (10) 1123-1127;
  2. Zhang, Shimin

    1. You have access
      Troglitazone Increases Cytochrome P-450 3A Protein and Activity in Primary Cultures of Human Hepatocytes
      Vinod Ramachandran, Vsevolod E. Kostrubsky, Bernard J. Komoroski, Shimin Zhang, Kenneth Dorko, James E. Esplen, Stephen C. Strom and Raman Venkataramanan
      Drug Metabolism and Disposition October 1999, 27 (10) 1194-1199;
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition: 27 (10)
Drug Metabolism and Disposition
Vol. 27, Issue 10
1 Oct 1999
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics